| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gorman Kevin Charles is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $82.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2020 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,390 | $118.91 | $403,101.17 | -0.8% | |
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 2,906 | $99.45 | $289,015.65 | -0.7% | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,248 | $103.35 | $335,696.07 | -0.7% | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 9,792 | $102.41 | $1,002,793.48 | -0.8% | |
| Aug 8, 2019 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 80,000 | $95.31 | $7,624,974.50 | -6.0% | |
| Feb 6, 2019 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 4,096 | $84.23 | $344,985.60 | -1.0% | |
| Feb 5, 2019 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 7,614 | $88.16 | $671,216.18 | -0.6% | |
| May 1, 2018 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 126,832 | $80.75 | $10,241,734.73 | -26.8% | |
| Feb 6, 2018 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 105,983 | $80.25 | $8,504,783.91 | -9.4% | |
| Jan 16, 2018 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,750 | $78.89 | $295,819.88 | -1.1% |